ZTS
Zoetis Inc - Ordinary Shares - Class A

3,604
Mkt Cap
$64.88B
Volume
1.57M
52W High
$184.41
52W Low
$139.34
PE Ratio
25.19
ZTS Fundamentals
Price
$146.39
Prev Close
$147.11
Open
$146.00
50D MA
$148.29
Beta
0.79
Avg. Volume
2.81M
EPS (Annual)
$5.47
P/B
13.06
Rev/Employee
$670,724.64
Loading...
Loading...
News
all
press releases
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Xeris Biopharma (XERS) Surges 14.2%: Is This an Indication of Further Gains?
Xeris Biopharma (XERS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Zacks·8d ago
News Placeholder
Zoetis Announces Health Canada Approval of Lenivia (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs
Zoetis Inc. today announced that Health Canada has approved Lenivia (izenivetmab injection) for the alleviation of pain associated with osteoarthritis (OA) in dogs. Built on a decade of science and...
Business Wire·9d ago
News Placeholder
Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks·10d ago
News Placeholder
Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain
ZTS secures CVMP's positive opinion recommending the approval of Lenivia, a long-acting OA pain therapy for dogs, with the final decision expected in late 2025.
Zacks·10d ago
News Placeholder
Zoetis Receives Positive Opinion from CVMP for Lenivia (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
Zoetis Inc. today announced that the Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of marketing...
Business Wire·13d ago
News Placeholder
Zoetis Declares Fourth Quarter 2025 Dividend
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.50 per share for the fourth quarter of 2025. The dividend will be paid on Tuesday, December 2, 2025, to all holders of...
Business Wire·14d ago
News Placeholder
SDZNY or ZTS: Which Is the Better Value Stock Right Now?
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
Zacks·25d ago
News Placeholder
Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing
Zoetis (ZTS) concluded the recent trading session at $143.5, signifying a +1.68% move from its prior day's close.
Zacks·27d ago
News Placeholder
Zoetis (ZTS) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, Zoetis (ZTS) stood at $146.25, denoting a -1.32% move from the preceding trading day.
Zacks·1mo ago

Latest ZTS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.